Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 37Alexion Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

RAVULIZUMAB-CWVZ

Brand Name : ULTOMIRIS

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 300MG/30ML(10MG/ML)

Packaging :

Approval Date :

Application Number : 761108

Regulatory Info :

Registration Country : USA

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1100mg/11ml

Packaging :

Approval Date : 18/11/2020

Application Number : 20191122000116

Regulatory Info : Approved

Registration Country : Sweden

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/3ml

Packaging :

Approval Date : 18/11/2020

Application Number : 20191122000109

Regulatory Info : Approved

Registration Country : Sweden

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/30ml

Packaging :

Approval Date : 02/07/2019

Application Number : 20180628000034

Regulatory Info : Approved

Registration Country : Sweden

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Injectable Solution

Dosage Strength : 245mg

Packaging :

Approval Date : 31/05/2023

Application Number : 20220216000012

Regulatory Info : Deregistered

Registration Country : Sweden

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomir

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/30ml

Packaging :

Approval Date : 20/01/2020

Application Number : 67278

Regulatory Info : Allowed

Registration Country : Switzerland

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomir

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/3ml

Packaging :

Approval Date : 20/01/2020

Application Number : 67278

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomir

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1100mg/11ml

Packaging :

Approval Date : 20/01/2020

Application Number : 67278

Regulatory Info : Allowed

Registration Country : Switzerland

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

RAVULIZUMAB

Brand Name : ULTOMIRIS

Dosage Form : SOLUTION

Dosage Strength : 10MG/ML

Packaging :

Approval Date :

Application Number : 2491559

Regulatory Info : Schedule D

Registration Country : Canada

blank

10

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

RAVULIZUMAB

Brand Name : ULTOMIRIS

Dosage Form : SOLUTION

Dosage Strength : 300MG/3ML

Packaging :

Approval Date :

Application Number : 2533448

Regulatory Info : Schedule D

Registration Country : Canada

blank

11

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

RAVULIZUMAB

Brand Name : ULTOMIRIS

Dosage Form : SOLUTION

Dosage Strength : 1100MG/11ML

Packaging :

Approval Date :

Application Number : 2533456

Regulatory Info : Prescription

Registration Country : Canada

blank

12

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

13

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

14

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

15

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

16

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

17

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

18

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

19

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

20

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank